109 related articles for article (PubMed ID: 38307576)
1. Investigation of Mirna-223-3p Expression in Non-small Cell Lung Cancers.
Barut Z; Akdeniz FT; Isbir T
Anticancer Res; 2024 Feb; 44(2):585-591. PubMed ID: 38307576
[TBL] [Abstract][Full Text] [Related]
2. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
Lu YJ; Liu RY; Hu K; Wang Y
Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic potential of a circRNA-miRNA network in non-small cell lung cancer.
Ma X; Lou C; Pan J; Zhou C; Zhao X; Li N; Tian H; Meng X
J Mol Med (Berl); 2023 Jun; 101(6):671-684. PubMed ID: 37069371
[TBL] [Abstract][Full Text] [Related]
7. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circFOXO3 facilitate non-small cell lung cancer progression through upregulating HMGB3 via sponging miR-545-3p/miR-506-3p.
Yang M; Zheng E; Ni J; Xu X; Jiang X; Zhao G
Tissue Cell; 2022 Apr; 75():101702. PubMed ID: 35038619
[TBL] [Abstract][Full Text] [Related]
9. circRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway.
Song HM; Meng D; Wang JP; Zhang XY
Dis Markers; 2021; 2021():8388512. PubMed ID: 34413915
[TBL] [Abstract][Full Text] [Related]
10. Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach.
Gulhane P; Nimsarkar P; Kharat K; Singh S
Oncotarget; 2022; 13():725-746. PubMed ID: 35634241
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
Tan T; Xu XH; Lu XH; Wang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
Dong Z; Liu H; Zhao G
Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
[No Abstract] [Full Text] [Related]
13. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
Feng H; Ge F; Du L; Zhang Z; Liu D
J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
15. miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer.
Liu X; Shi H; Liu B; Li J; Liu Y; Yu B
Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):431-40. PubMed ID: 25935837
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
[TBL] [Abstract][Full Text] [Related]
17. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
18. Two microRNAs of plasma-derived small extracellular vesicles as biomarkers for metastatic non-small cell lung cancer.
Geng N; Qi Y; Qin W; Li S; Jin H; Jiang Y; Wang X; Wei S; Wang P
BMC Pulm Med; 2023 Jul; 23(1):259. PubMed ID: 37452310
[TBL] [Abstract][Full Text] [Related]
19. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
Zeng X; Liu D; Peng G; Liu J; Yang H
Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression.
Zhang H; Wang X; Hu B; Zhang F; Wei H; Li L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3410-3416. PubMed ID: 31407591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]